These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 20578221)

  • 1. Second device for a patent foramen ovale: life saver and psychotherapy.
    Meier B
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):151-2. PubMed ID: 20578221
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of residual shunts after initial percutaneous patent foramen ovale closure: a single center experience with immediate and long-term follow-up.
    Diaz T; Cubeddu RJ; Rengifo-Moreno PA; Cruz-Gonzalez I; Solis-Martin J; Buonanno FS; Inglessis I; Palacios IF
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):145-50. PubMed ID: 20578100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent foramen ovale.
    Silva GV
    Tex Heart Inst J; 2014 Jun; 41(3):306-8. PubMed ID: 24955048
    [No Abstract]   [Full Text] [Related]  

  • 5. Residual shunt after percutaneous closure of patent foramen ovale with AMPLATZER occluder devices - influence of anatomic features: a transcranial Doppler and intracardiac echocardiography study.
    Marchese N; Pacilli MA; Inchingolo V; Fanelli R; Loperfido F; Vigna C
    EuroIntervention; 2013 Jul; 9(3):382-8. PubMed ID: 23872652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.
    Luna M; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2010; 11(1):63-6. PubMed ID: 20129363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coil closure of residual shunt after Amplatzer PFO occlusion.
    Meier B
    Catheter Cardiovasc Interv; 2011 Apr; 77(5):720-1. PubMed ID: 20939039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of different devices for transcatheter closure of patent foramen ovale assessed by serial transoesophageal echocardiography and rates of recurrent cerebrovascular events in a long-term follow-up.
    Luani B; Markovic S; Krumsdorf U; Rottbauer W; Wöhrle J
    EuroIntervention; 2015 May; 11(1):85-91. PubMed ID: 25572024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patent foramen ovale closure in children without cardiopathy: Child-PFO study.
    Miton N; Godart F; Milani G; Jalal Z; Karsenty C; Baruteau AE; Gronier C; Aldebert P; Douchin S; Lucron H; Chalard A; Houeijeh A; Petit J; Hascoet S; Thambo JB; Dauphin C
    Arch Cardiovasc Dis; 2020; 113(8-9):513-524. PubMed ID: 32680737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter Patent Foramen Ovale Closure After Cryptogenic Stroke: An Updated Meta-Analysis of Randomized Trials.
    Mojadidi MK; Elgendy AY; Elgendy IY; Mahmoud AN; Elbadawi A; Eshtehardi P; Patel NK; Wayangankar S; Tobis JM; Meier B
    JACC Cardiovasc Interv; 2017 Nov; 10(21):2228-2230. PubMed ID: 29122137
    [No Abstract]   [Full Text] [Related]  

  • 11. Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud® in patients with stroke or transient ischemic attack.
    Steinberg DH; Bertog SC; Momberger J; Franke J; Hofmann I; Renkhoff K; Joy S; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1262-7. PubMed ID: 24948394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous patent foramen ovale closure using the Occlutech Figulla device: More than 1,300 patient-years of follow up.
    Snijder RJR; Renes LE; Suttorp MJ; Ten Berg JM; Post MC
    Catheter Cardiovasc Interv; 2019 May; 93(6):1080-1084. PubMed ID: 30461175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stroke due to late device thrombosis following successful percutaneous patent foramen ovale closure.
    Korabathina R; Thaler DE; Kimmelstiel C
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):498-502. PubMed ID: 21953702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patent Foramen Ovale Closure for Stroke Prevention and Other Disorders.
    Collado FMS; Poulin MF; Murphy JJ; Jneid H; Kavinsky CJ
    J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29910192
    [No Abstract]   [Full Text] [Related]  

  • 15. Transcatheter PFO closure with GORE(®) septal occluder: early and mid-term clinical results.
    Butera G; Saracino A; Danna P; Sganzerla P; Chessa M; Carminati M
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):944-9. PubMed ID: 23897659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should we close hypoxaemic patent foramen ovale and interatrial shunts on a systematic basis?
    Juliard JM; Aubry P; Ducrocq G; Lepage L; Brochet E
    Arch Cardiovasc Dis; 2009 Nov; 102(11):739-41. PubMed ID: 19944388
    [No Abstract]   [Full Text] [Related]  

  • 17. Pacemaker lead entrapment complicating transcatheter closure of a patent foramen ovale.
    Quevedo HC; Arain SA; Abi Rafeh N
    JACC Cardiovasc Interv; 2014 Nov; 7(11):e171-2. PubMed ID: 25459047
    [No Abstract]   [Full Text] [Related]  

  • 18. Residual shunting after percutaneous PFO closure: how to manage and how to close.
    Butera G; Sarabia JF; Saracino A; Chessa M; Piazza L; Carminati M
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):950-8. PubMed ID: 23804551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioembolic stroke: who is the guilty?
    Gaio G; Santoro G; Palladino MT; Iacono C; Castaldi B; Russo MG; Calabrò R
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):370-2. PubMed ID: 20613549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
    Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
    Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.